Tomokazu Shoji, Manabu Akazawa, Nonoka Nakagomi, Miwako Kobayashi, Fumihiko Kitta, Ryo Inose, Yuichi Muraki, Tetsuya Iijima, Takaaki Suzuki. Trends of Strong and Weak Opioid Prescriptions in Japan: A Cross-Sectional Study Based on Open Data from the National Database and Hospital Claims Data from Fiscal Years 2015 to 2021. Biological and Pharmaceutical Bulletin. 2025. 48. 3. 279-285
Ryota Goto, Ryo Inose, Tomokazu Shoji, Manabu Akazawa, Yuichi Muraki. Current status and challenges of health economic evaluations related to antimicrobial stewardship in Japan: A scoping review up to 2023. Journal of Infection and Chemotherapy. 2025. 31. 3. 102657-102657
Tomokazu Shoji, Manabu Akazawa, Osamu Inoue, Takaaki Suzuki. Trends in syphilis treatments and the impact of intramuscular injectable Benzathine penicillin G in Japan: A descriptive study using administrative claims data from April 2016 to September 2023. Journal of Infection and Chemotherapy. 2025. 31. 3. 102586-102586
Tomokazu Shoji, Natsu Sato, Haruhisa Fukuda, Yuichi Muraki, Keishi Kawata, Manabu Akazawa. Clinical Implication of the Relationship between Antimicrobial Resistance and Infection Control Activities in Japanese Hospitals: A Principal Component Analysis-Based Cluster Analysis. Antibiotics (Basel, Switzerland). 2022. 11. 2
Tomokazu Shoji, Ryusei Muto, Ryoko Sakai, Hiroki Matsumura, Takashi Uchida, Fumihiko Kitta, Osamu Inoue, Keishi Kawata, Manabu Akazawa. Estimated medical costs of methicillin-resistant Staphylococcus aureus infection classified by polymerase chain reaction-based open reading frame typing in Japan. AIMS Microbiology. 2022. 8. 4. 528-543